|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
NK-��B |
|
��� |
| ��������������� | |
|
������ |
|
֣ï�� |
|
����Դ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
������-��B����м�����о���չ
������, ֣ï��, ����Դ
�ڶ���ҽ��ѧ����ҽԺƤ����, �Ϻ�200433
������-��B��һ���ֲ��㷺��ת¼����,��ͨ������ϸ�����ӡ��������ӡ��������ӡ�ճ�����ӵ���ػ���ı��,��������Ӧ����֢��Ӧ��ϸ�������������������(��)������̡��������˺�����-��B��Ƥ����֢��Ӧ�еĻ���̼�������м��֮��Ŀ��ܹ�ϵ��
[2] Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med, 1999, 341 (24):1817-1828.
[3] Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest, 2001, 107(2):135-142.
[4] Tak PP, Firestein GS. NF-kappaB:a key role in inflammatory diseases. J Clin Invest, 2001, 107 (1):7-11.
[5] Foo SY, Nolan GP. NF-kappaB to the rescue:RELs, apoptosis and cellular transformation. Trends Genet, 1999, 15 (6):229-235.
[6] Rodriguez MS, Thompson J, Hay RT, et al. Nuclear retention of Ikap paBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J Biol Chem, 1999. 274 (13):9108-9115.
[7] Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB ki nase. Science, 1999, 284(5412):316-320.
[8] Hu Y, Baud V, Oga T, et al. IKKalpha controls formation of the epi dermis independently of NF-kappaB. Nature, 2001, 410(6829):710-714.
[9] Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous in flammation:a crucial link between innate and acquired immunity. J Invest Dermatol, 2000, 114 (3):602-608.
[10] Freedberg IM, Tomic-Canic M, Komine M, et al. Keratins and the ke ratinocyte activation cycle. J Invest Dermatol, 2001, 116 (5):633-640.
[11] Karin M. The beginning of the end:IkappaB kinase (IKK) and NF kappaB activation. J Biol Chem, 1999, 274 (39):27339-27342.
[12] Hawiger J. Innate immunity and inflammation:a transcriptional para digm. Immunol Res, 2001,23(2-3):99-109.
[13] Kwon YW, Jang ER, Lee YM, et al. Insulin-like growth factor �� induces interleukin-6 expression via NFkappaB activation in psoriasis. Biochem Biophys Res Commun, 2000, 278 (2):312-317.
[14] Aragane Y, Yamada H, Schwarz A, et al. Transforming growth factor alpha induces interleukin-6 in the human keratinocyte cell line HaCaT mainly by transcriptional activation. J Invest Dermatol, 1996, 106(6):1192-1197.
[15] Klement JF, Rice NR, Car BD, et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol, 1996, 16(5):2341-2349.
[16] Chen CL, Singh N, Yull FE,et al. Lymphocytes lacking I kappa B-al pha develop normally, but have selective defects in proliferation and function. J Immunol, 2000,165 (10):5418-5427.
[17] Kaufman CK, Fuchs E. It's got you covered. NF-kappaB in the epidermis. J Cell Biol, 2000, 149(5):999-1004.
[18] Chen CL, Yull FE, Cardwell N, et al. RAG2-/-, I kappa B-alpha-/chimeras display a psoriasiform skin disease. J Invest Dermatol, 2000, 115(6):1124-1133.
[19] Aronica MA, Mora AL, Mitchell DB, et al. Preferential role for NFkappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol, 1999, 163(9):5116-5124.
[20] Zollner TM, Podda M, Pien C,et al. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest, 2002, 109(5):671-679.
[21] Boehncke WH, Zollner TM, Dressel D, et al. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model. J Cutan Pathol, 1997, 24(1):1-7.
[22] Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathysimilar to the human X-linked disorder incontinentia pigmenti. Mol Cell, 2000, 5(6):969-979.
[23] Schmidt-Ullrich R, Aebischer T, Hulsken J, et al. Requirement of NF kappaB/Rel for the development of hair follicles and other epidermal appendices. Development, 2001, 128(19):3843-3853.
[24] Chaturvedi V, Qin JZ, Denning MF, et al. Apoptosis in proliferating,senescent, and immortalized keratinocytes. J Biol Chem, 1999, 274 (33):23358-23367.
[25] Seitz CS, Freiberg RA, Hinata K, et al. NF-kappaB determines locali zation and features of cell death in epidermis. J Clin Invest, 2000, 105 (3):253-260.